课题基金 / 基金详情

项目摘要

项目成果

JAE HO KIM的其他基金

相似基金

相关文献

中文摘要
翻译
中枢神经系统(CNS)是所有正常组织中维持协调正常功能最关键的组织。辐射暴露后,中枢神经系统的反应可归因于实质和血管损伤,包括少突胶质细胞、神经祖细胞和内皮细胞。辐射诱导靶细胞死亡的动态过程和随后的继发性反应性炎症过程被认为会导致细胞损失、组织损伤和功能缺陷。可以说比身体更重要
英文摘要
The central nervous system (CNS) is the most critical of all normal tissues for maintaining coordinated normal function. Following radiation exposure, the response of the CNS has been attributable to parenchymal and vascular damages including oligodendrocytes, neural progenitors, and endothelial cells. A dynamic process of radiation-induced death of target cells and subsequent secondary reactive inflammatory process is believed to lead to cell loss, tissue damage and functional deficits. Arguably of greater consequence than the physical damage is the psychological impact of CNS injury which could result in the loss of sight, paralysis or reduced cognitive function. The only investigational demonstration of pharmacological mitigation of CNS radiation damage was recently made by our group using the Angiotensin Converting Enzyme (ACE) inhibitor, ramipril (an FDA-approved drug). Of note, a reduction of injury assessed functionally and histopathologically was observed even when ramipril was administered weeks after the radiation exposure. This project is based on the hypothesis that the suppression of oxidative stress resulting from multi-cellular interactions through a network of pro-inflammatory mediators would mitigate radiation-induced brain injury by specific pharmacological treatment. Three classes of drugs are well known to suppress oxidative stress and two of them, ACE inhibitors and their receptor blockers and statins are widely used in various cardiovascular disorders in humans. The project aims to address specific therapeutic roles of three classes of drugs, ACE inhibitors and receptor blockers, statins, and SOD mimetics, in all phases of the brain injury, i.e., acute, early delayed, and late delayed reactions. The primary goal is to demonstrate their efficacy and to optimize the use of drug dosage and timing of the administration to mitigate and treat the radiation brain injury. End points for evaluation are cognitive functions, visual function, MRI for permeability of the blood brain barrier, and histopathological and proliferative changes for neurogenesis, vascular and glial cells, using single doses of whole brain radiation of the adult rats. The positive findings from the proposed study will be readily translatable in humans, since both ACE inhibitors and statins are widely used in a variety of cardiovascular disorders in the clinics. In summary, experimental studies suggest radiation-induced CNS injury can be treated. The goal of this project is to bring one or more of these experimental approaches into clinical practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitigating Cutaneous Radiation Injury with CXCR4 Antagonist
  • 批准号:
    7963624
  • 项目类别:
  • 资助金额:
    $14.65万
  • 财政年份:
    2010
  • 负责人:
    JAE HO KIM
  • 依托单位:
Mitigating Cutaneous Radiation Injury with CXCR4 Antagonist
  • 批准号:
    8125035
  • 项目类别:
  • 资助金额:
    $25.38万
  • 财政年份:
    2010
  • 负责人:
    JAE HO KIM
  • 依托单位:
Mitigating and treating radiation-induced CNS injury
  • 批准号:
    7055649
  • 项目类别:
  • 资助金额:
    $46.39万
  • 财政年份:
    2005
  • 负责人:
    JAE HO KIM
  • 依托单位:
Suicide Gene and Radiation Therapy Clinical Trials
  • 批准号:
    6990166
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2004
  • 负责人:
    JAE HO KIM
  • 依托单位:
海外基金